期刊文献+

抗地高辛人源小分子抗体的构建

Construction of soluble anti-digoxin ScFv antibodies and diabody
下载PDF
导出
摘要 目的:将从大容量噬菌体抗体库中筛选得到的人源抗地高辛单链抗体进行分泌表达,并构建Diabody(双体抗体)。方法:将抗地高辛的噬菌体抗体转染HB2151菌(无琥珀抑制基因的宿主菌),IPTG诱导,制备抗地高辛的可溶性单链抗体。选取活性较好的克隆进行基因改造,构建Diabody表达载体,并分泌表达,表达Diabody进行Western blot鉴定。结果:经ELISA结合活性测定,得到了结合活性较高的抗地高辛的可溶性单链抗体;基因改造后,经ELISA及Western blot测定证实获得了结合活性较好的抗地高辛Diabody。结论:实验获得了分泌表达活性可靠的人源性抗地高辛抗体,并改造成应用前景较好的Diabody,为临床诊断及治疗洋地黄类药物中毒提供具有实用价值的人源小分子抗体。 Objective:To clone soluble human anti-digoxin antibodies from large phage antibody library and construct a vector that expresses diabody.Methods: Soluble ScFvs were prepared through infecting E coli. HB2151 with the selected phage antibodies and induced with IPTG. The diabody vector was modified by enzyme digestion and checked by SDS- electrophoretogram. Results: It was showed by ELISA that soluble ScFv had specific binding ability to digoxin. The vector to express a soluble diabody was obtained by genetic modification, which was shown by Western blot. Conclusion: Soluble human anti-digoxin antibodies were successfully obtained from phage antibodies. The vector is efficient in creating diabody.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2009年第2期167-170,共4页 Chinese Journal of Immunology
关键词 抗地高辛抗体 单链抗体 DIABODY Anti-digoxin ScFv Diabody
  • 相关文献

参考文献11

  • 1李家泰.临床药理学[M].第2版.北京:人民卫生出版社,1998:1 199.
  • 2Griffiths A D, Williams S C, Hartley O et al. Isolation of high affinity human antibodies directly from large synthetic repertoire[J]. EMBO J, 1994; 13 ( 14 ) : 3245-3260.
  • 3陈宇萍,张国民,乔媛媛,王刚,刘玉峰,化冰,王琰.大容量人源噬菌体抗体库的构建[J].中国免疫学杂志,2006,22(5):463-466. 被引量:9
  • 4Holliger P, Prospero T, Winter Get al. "Diabodies" : small bivalent and bispecific antibody fragments [J]. Proc Natl Acad Sci USA, 1993; 90 (14) : 6444-6448.
  • 5Lawrence L J, kortt A A, Iiades Pet al. Orientation of antigigen binding sites in dimeric and trimeric single chain Fv antibody fragments[J]. FEBS Letters, 1998 ; 425 : 479-484.
  • 6陈宇萍,王琰,王雅明,刘群英,朱迎春,化冰,高荣凯.抗红细胞双价小分子抗体的构建及表达[J].中华微生物学和免疫学杂志,1997,17(3):231-234. 被引量:9
  • 7Bowen C A, Krenzelok E P. Clinical applications of commonly used contemporary antidotes[J]. Drug Saf, 1997; 16(7) :9-14.
  • 8Breedveld F C. Therapeutic monoclonal antibodie[ J]. Lancet, 2000; 355 (9205) :735-740.
  • 9Aujama L, Geoffroy F, Sodoyer R. High affinity human antibodies by phage display[J]. Human Antibodies, 1997;8(35) : 155-168.
  • 10王琰,王欲晓,陈晓穗,化冰,刘晓琳.用于大容量噬菌体抗体库的表达载体的构建及鉴定[J].中国免疫学杂志,2003,19(2):93-96. 被引量:6

二级参考文献15

  • 1王琰,刘群英,化冰,朱迎春,王雅明,徐建军.金属螯合亲和层析法对抗HBs Fab段的纯化[J].中华微生物学和免疫学杂志,1996,16(2):104-107. 被引量:8
  • 2Hoess R H,Abremski K.Interaction of the bacteriophage P1 recombinase Cre with the recombining site loxP[J].Proc Natl Acad Sci USA,1984 ;81 (4):1026-1029.
  • 3Griffiths A D,Williams S C,Hartley O et al.Isolation of high affinity human antibodies directly from large synthetic repertoire[J].EMBO J,1994;13:3245-3260.
  • 4Sblattero D,Bradbury A.Exploiting recombination in single bacteria to make large phage antibody libraries[J].Nat Biotechnol,2000;18:74-80.
  • 5Holliger P,Prospero T,Winter G."Diabodies":small bivalent and bispecific antibody fragments[J].Proc Natl Acad Sci USA,1993;90:6444-6448.
  • 6Lawrence L J,kortt A A.Iiades P et al.Orientation of antigigen binding sites in dimeric and trimeric single chain Fv antibody fragments[J].FEBS Letters,1998;425:479-484.
  • 7Vanghan T J,Williams S C,Pritchard K et al.Human antibody with subnanomolar affinities isolated from a large nonimmunized phage display library[J].Nat Biotechnol,1996;14:309-314.
  • 8Holliger P,Manzke O,Span M et al.Carcinoembryonic antigen(CEA)-specific T-cell activation in colon carcinoma induced by antiCD3×anti-CEA bispecific dabodies and B7×anti-CEA bispecific fusion proteins[J].Cancer Res,1999 ;59:2909-2916.
  • 9王琰,刘群英,高荣凯,朱迎春,化冰,王雅明,徐建军.单链抗体(ScFv)表达载体的构建及抗 HBs ScFv 的表达[J].中华微生物学和免疫学杂志,1997,17(1):68-71. 被引量:13
  • 10陈宇萍,王琰,王雅明,刘群英,朱迎春,化冰,高荣凯.抗红细胞双价小分子抗体的构建及表达[J].中华微生物学和免疫学杂志,1997,17(3):231-234. 被引量:9

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部